Tagged stem-cell
Press Release
Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy and Clinical Candidate SR-02 for Insulin-Requiring Diabetes; Oral Presentation at IPITA
Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and in vivo function. Dr. William Rust, CEO of Seraxis, will deliver a lecture at the IPITA-IXA-CTRMS Joint Congress on October 29 at 10:00 a.m. in San Diego entitled “Novel stem cell-derived islet-like clusters potently control rodent blood glycemia”. Seraxis will be taking meetings at BIO-Europe, November 6-8, in Munich. Read More
Press Release
Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD
Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets for Treating Diabetes”, will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow". Read More
Press Release
Natural Skincare Brand, Frownies, Releases New Skin-Renewing Apple Serum With the Power of Plant-Based Stem Cell Technology
Frownies, best known for its wrinkle-smoothing Facial Patches, uses the latest advancements in regenerative medicine to combat fine lines and aging skin Read More
Press Release
Treating COVID-19: BioXcellerator Granted Regulatory Approval for Major Clinical Trial on Stem Cell Therapy
Leading U.S-based stem cell research and treatment company begins clinical trial — similar to one just approved by the FDA and first such study ever approved by Colombian government healthcare regulator. Read More
Press Release
Alliance for Stem Cell Therapy Now and American Academy of Stem Cell Physicians Hosting Safety Industry Panel
Alliance for Stem Cell Therapy Now Ms. Janet Marchibroda will moderate the Safety industry panel hosted by AASCP in Miami on November 2, 2019 and will be broadcast live. Read More
Press Release
Stem Cell Rejuvenation Enterprises Operates in Partnership With Dr. Roxana Kerns at the New Manhattan Location Offering the Priapus Shot® and the O-Shot® Procedures Under Anesthesia Care
Corina Ianculovici, RN, CRNI, MEP-C and founder of Stem Cell Rejuvenation Enterprises, the parent company of Mirelle MediSpa, in partnership with Dr. Roxana Kerns, a Board Certified Anesthesiologist will be performing the Priapus Shot® and the O-Shot® under optimal anesthesia care in their new Manhattan location. Read More
Press Release
Sarasota Orthopedic Dr Sugar Partners With the Best in the Business for Regenerative Medicine
Dr. Sugar and his team of medical professionals are set to offer state-of-the-art regenerative medicine to Sarasota and patients in the surrounding area. Regenerative medicine offers a powerful alternative to surgery, using the body's natural ability to heal itself and implementing it into treating injuries ranging from tennis elbow to arthritis. In pursuit of offering regenerative medicine, Dr. Sugar has teamed up with two of the most respected and experienced organizations available. Read More
Press Release
Medtown Ventures, LLC Announces Exclusive License Agreement With Georgia Tech Research Corporation
Medtown Ventures forms a new company, CellectCell Inc., to focus on commercialization of adhesive-signature based cell selection technology invented and patented by Georgia Tech -- Read More
Press Release
ReeLabs to Expand Stem Cell Operations in Karantaka to Set Up Facility and Invest Rs. 50 Crore
Mumbai-based Reelabs has now set its sights on Karnataka to expand its operations. The company has earmarked Rs.50 crore to establish a facility near Bengaluru for its research. This apart it is looking to set up a dedicated stem cell hospital here. Read More
Press Release